Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Open in Screener

CDNA

Caredx Inc

May 03 • 04:00PM ET

9.72

Dollar change +0.45
Percentage change 4.85	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: ARKG VTI IWM VXF VB IWN VBK IBB LABU DFAT

Index	RUT	P/E	-	EPS (ttm)	-3.55	Insider Own	6.04%	Shs Outstand	51.50M	Perf Week	28.57%
Market Cap	505.54M	Forward P/E	-	EPS next Y	-1.32	Insider Trans	0.00%	Shs Float	48.91M	Perf Month	-0.82%
Income	-190.28M	PEG	-	EPS next Q	-0.47	Inst Own	95.63%	Short Float	9.59%	Perf Quarter	11.47%
Sales	280.32M	P/S	1.80	EPS this Y	55.36%	Inst Trans	-1.84%	Short Ratio	5.80	Perf Half Y	79.67%
Book/sh	5.07	P/B	1.92	EPS next Y	16.67%	ROA	-36.40%	Short Interest	4.69M	Perf Year	14.08%
Cash/sh	4.53	P/C	2.15	EPS next 5Y	20.00%	ROE	-54.98%	52W Range	4.80 - 12.93	Perf YTD	-19.00%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-21.96%	ROI	-65.70%	52W High	-24.83%	Beta	1.63
Dividend TTM	-	Quick Ratio	3.77	Sales past 5Y	33.42%	Gross Margin	62.74%	52W Low	102.50%	ATR (14)	0.69
Dividend Ex-Date	-	Current Ratio	4.02	EPS Y/Y TTM	-147.12%	Oper. Margin	-37.01%	RSI (14)	58.73	Volatility	10.14% 6.35%
Employees	643	Debt/Eq	0.13	Sales Y/Y TTM	-12.89%	Profit Margin	-67.88%	Recom	1.71	Target Price	13.00
Option/Short	Yes / Yes	LT Debt/Eq	0.11	EPS Q/Q	-546.03%	Payout	-	Rel Volume	1.05	Prev Close	9.27
Sales Surprise	3.00%	EPS Surprise	-394.74%	Sales Q/Q	-20.41%	Earnings	May 09 AMC	Avg Volume	809.41K	Price	9.72
SMA20	13.91%	SMA50	1.29%	SMA200	7.23%	Trades		Volume	846,431	Change	4.85%

Date	Action	Analyst	Rating Change	Price Target Change
May-01-24	Upgrade	Craig Hallum	Hold → Buy	$15
Nov-09-23	Upgrade	Stephens	Equal-Weight → Overweight	$10
Aug-15-23	Upgrade	Raymond James	Mkt Perform → Outperform	$12
May-11-23	Downgrade	BTIG Research	Buy → Neutral
Mar-07-23	Downgrade	Stephens	Overweight → Equal-Weight	$19 → $9
Mar-03-23	Downgrade	Raymond James	Strong Buy → Mkt Perform
Mar-03-23	Downgrade	Craig Hallum	Buy → Hold	$26 → $9
Apr-25-22	Initiated	Stephens	Overweight	$50
Jul-20-21	Resumed	BTIG Research	Buy	$115
Jun-03-21	Initiated	Goldman	Buy	$95
Feb-26-21	Downgrade	H.C. Wainwright	Buy → Neutral
Oct-30-20	Reiterated	H.C. Wainwright	Buy	$47 → $55
Oct-08-20	Reiterated	H.C. Wainwright	Buy	$45 → $47
Oct-02-20	Reiterated	H.C. Wainwright	Buy	$40 → $45
Aug-05-20	Reiterated	H.C. Wainwright	Buy	$37 → $40
Jun-26-20	Initiated	BTIG Research	Buy	$40
Jun-19-20	Reiterated	H.C. Wainwright	Buy	$40 → $37
Oct-01-19	Resumed	Craig Hallum	Buy	$48
May-09-19	Upgrade	H.C. Wainwright	Neutral → Buy	$30 → $43
Feb-15-19	Initiated	Jefferies	Buy	$35

Show Previous Ratings

May-03-24 04:10PM	CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-29-24 04:05PM	CareDx to Report First Quarter 2024 Financial Results (Business Wire) +8.47%
Apr-19-24 04:05PM	CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Apr-18-24 03:47AM	CareDx (CDNA) Moves 5.5% Higher: Will This Strength Last? (Zacks)
Apr-16-24 04:02PM	CareDx Appoints John W. Hanna as its New President and Chief Executive Officer (Business Wire)
07:00AM	Loading…
Apr-09-24 07:00AM	CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting (Business Wire)
Apr-01-24 08:40AM	How CareDx (CDNA) Stock Stands Out in a Strong Industry (Zacks)
Mar-11-24 04:10PM	CareDx Appoints Bryan Riggsbee to Its Board of Directors (Business Wire)
Feb-29-24 10:43AM	CareDx, Inc (NASDAQ:CDNA) Q4 2023 Earnings Call Transcript (Insider Monkey) +9.47%
06:59AM	Q4 2023 CareDx Inc Earnings Call (Thomson Reuters StreetEvents)
Feb-28-24 07:00PM	CareDx (CDNA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
05:28PM	CareDx: Q4 Earnings Snapshot (Associated Press Finance)
04:57PM	CareDx Inc (CDNA) Surpasses Revenue Expectations Despite Net Loss Expansion in 2023 (GuruFocus.com)
04:05PM	CareDx Announces Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Feb-27-24 04:05PM	CareDx to Participate in the Raymond James & Associates 45th Annual Institutional Investors Conference (Business Wire) +6.39%
09:15AM	Loading…
Feb-26-24 09:15AM	Unlocking Q4 Potential of CareDx (CDNA): Exploring Wall Street Estimates for Key Metrics (Zacks) +7.86%
Feb-21-24 04:05PM	CareDx to Report Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
07:00AM	CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings (Business Wire)
Jan-26-24 09:45PM	CareDx Issues Statement in Patent Infringement Case (Business Wire) -17.32%
Jan-11-24 04:05PM	CareDx Adds to AlloSure Kidney and HeartCare Utility and Clinical Data at 2024 American Society of Transplant Surgeons Winter Symposium (Business Wire) -7.24%
Jan-09-24 07:00AM	CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2023 (Business Wire)
Dec-19-23 07:00AM	CareDx Joins Forces with the National Foundation for Transplants to Improve Post-Transplant Medication Adherence (Business Wire) +13.81%
Dec-08-23 09:55AM	How Much Upside is Left in CareDx (CDNA)? Wall Street Analysts Think 26.72% (Zacks)
Nov-22-23 09:55AM	Can CareDx (CDNA) Climb 29.79% to Reach the Level Wall Street Analysts Expect? (Zacks)
Nov-10-23 10:15AM	CareDx, Inc (NASDAQ:CDNA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 05:02PM	CareDx: Q3 Earnings Snapshot (Associated Press Finance)
04:05PM	CareDx Reports Third Quarter 2023 Results (Business Wire)
Nov-06-23 07:38AM	CareDx (CDNA) Surges 16.6%: Is This an Indication of Further Gains? (Zacks)
Nov-02-23 04:05PM	CareDx to Report Third Quarter 2023 Financial Results (Business Wire) +9.98%
Nov-01-23 04:02PM	CareDx Announces CEO Transition (Business Wire)
07:00AM	Loading…
Oct-17-23 07:00AM	CareDx Presents New Data at the American Society for Histocompatibility and Immunogenetics Annual Meeting (Business Wire)
Oct-03-23 07:12PM	Market Today: Tech Stocks Under Pressure, House Ousts McCarthy, and FTC Accuses Amazon of Price ... (GuruFocus.com)
06:00PM	CareDx Issues Statement on Supreme Court Decision Regarding Stanford-Licensed Patents (Business Wire)
04:43PM	Supreme Court Denies CareDx Request for Appeal in Patent Case with Natera (Business Wire)
Oct-02-23 11:06AM	US Supreme Court rebuffs CareDx patent lawsuit over organ-rejection tests (Reuters)
Sep-19-23 07:00AM	CareDx To Present at the 2023 Cantor Global Healthcare Conference (Business Wire)
Sep-14-23 02:00AM	CareDx Advances Global Transplant Patient Care at ESOT Congress 2023 (Business Wire)
Aug-31-23 07:00AM	CareDx To Present at the H.C. Wainwright 25th Annual Global Investment Conference (Business Wire)
Aug-17-23 07:00AM	CareDx Hosts Second Annual MEET Digital Health User Conference to Showcase Latest Innovations to Enhance Transplant Patient Care (Business Wire)
Aug-15-23 09:59AM	Redfin upgraded, CSSE downgraded: Wall Street's top analyst calls (The Fly)
Aug-11-23 07:00AM	CareDx Comments on Issuance of Proposed LCD for Molecular Testing for Solid Allograft Rejection (Business Wire) -8.06%
Aug-09-23 09:30AM	Compared to Estimates, CareDx (CDNA) Q2 Earnings: A Look at Key Metrics (Zacks) -11.23%
Aug-08-23 06:05PM	CareDx (CDNA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:02PM	CareDx: Q2 Earnings Snapshot (AP Finance)
04:05PM	CareDx Reports Second Quarter 2023 Results (Business Wire)
Aug-07-23 11:08AM	CareDx Announces District Court Judge Bars Natera from Falsely Advertising and Overstating the Scientific Performance of its Prospera Transplant Test (Business Wire)
Aug-03-23 07:00AM	CareDx to Report Second Quarter 2023 Financial Results (Business Wire)
Aug-02-23 07:00AM	CareDxs HeartCare Multimodality Service Receives Medicare Coverage for Heart Transplant Surveillance (Business Wire) +7.34%
Jul-25-23 07:00AM	CareDx Acquires MediGO, an Organ Transplant Supply Chain and Logistics Company (Business Wire) +5.76%
Jul-17-23 11:42PM	CareDx Applauds District Court Decision to Uphold Jury Verdict that Natera Falsely Advertised its Prospera Transplant Test (Business Wire)
Jul-11-23 07:00AM	CareDxs AlloSure Lung dd-cfDNA Testing Service Receives Medicare Coverage for Lung Transplant Rejection Monitoring (Business Wire) +6.49%
Jul-10-23 08:44AM	CareDx (CDNA) Soars 20.6%: Is Further Upside Left in the Stock? (Zacks)
Jul-07-23 12:26PM	Why Shares of CareDx Are Jumping Friday (Motley Fool) +20.55%
Jul-05-23 06:08AM	We're Hopeful That CareDx (NASDAQ:CDNA) Will Use Its Cash Wisely (Simply Wall St.)
Jun-01-23 08:00AM	CareDx Demonstrates Innovation Leadership at 2023 Transplant Congress (Business Wire)
07:00AM	CareDx to Participate in Upcoming Investor Conferences (Business Wire)
May-16-23 07:00AM	CareDx Showcases Digital Health Portfolio at 31st Annual UNOS Transplant Management Forum (Business Wire) -6.83%
06:42AM	Should You Exit CareDx (CDNA)? (Insider Monkey)
06:02AM	What Does The Future Hold For CareDx, Inc (NASDAQ:CDNA)? These Analysts Have Been Cutting Their Estimates (Simply Wall St.)
May-11-23 10:13AM	Q1 2023 CareDx Inc Earnings Call (Thomson Reuters StreetEvents)
May-10-23 05:45PM	CareDx (CDNA) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:43PM	CareDx: Q1 Earnings Snapshot (AP Finance)
04:05PM	CareDx Reports First Quarter 2023 Results (Business Wire)
May-08-23 07:01AM	CareDx to Report First Quarter 2023 Financial Results (Business Wire)
Apr-25-23 06:01AM	CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility Conference (Business Wire) -5.21%
Apr-19-23 07:01AM	CareDx Showcases Leadership with Over 55 Oral Presentations and Posters at the 43rd Annual Meeting & Scientific Sessions of the International Society for Heart and Lung Transplantation (Business Wire)
Apr-18-23 01:22PM	CareDx, Inc's (NASDAQ:CDNA) Shares Lagging The Industry But So Is The Business (Simply Wall St.)
Apr-06-23 07:01AM	National Kidney Foundation Honors CareDx with Corporate Citizenship Award for its Commitment to the Transplant Community (Business Wire)
Apr-05-23 06:55AM	CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation (Business Wire)
Mar-23-23 07:01AM	CareDx Presents Latest Advancements at 12th Congress of the International Pediatric Transplant Association (Business Wire)
Mar-11-23 02:46AM	CareDx, Inc (NASDAQ:CDNA) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-07-23 07:01AM	The American Society of Transplant Surgeons Position Statement Supports Use of CareDxs AlloSure Kidney for Organ Transplant Surveillance (Business Wire)
Mar-06-23 04:32PM	CareDx Update Regarding Raymond James & Associates Conference (Business Wire) +18.73%
07:01AM	CareDx To Participate in the Raymond James & Associates 44th Annual Institutional Investors Conference (Business Wire)
Mar-03-23 04:01PM	CareDx Earns Stock Downgrade Amid CMS Coverage Cuts Change Thesis (Benzinga) -16.67%
07:01AM	CareDx Comments on MolDX Publication of New Billing and Coding Article (Business Wire)
Mar-01-23 07:01AM	CareDx Key Supporter of the National Kidney Foundations Annual Kidney Patient Summit (Business Wire)
05:19AM	CareDx Full Year 2022 Earnings: In Line With Expectations (Simply Wall St.)
Feb-28-23 09:58AM	Q4 2022 CareDx Inc Earnings Call (Thomson Reuters StreetEvents) +14.34%
Feb-27-23 05:15PM	CareDx (CDNA) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:01PM	CareDx Reports Fourth Quarter and Full Year 2022 Results (Business Wire)
06:28AM	Baron Discovery Fund Believes CareDx (CDNA) Will Reward Investors for Patience (Insider Monkey)
Feb-22-23 07:01AM	CareDx Showcases Clinical Value of Multimodality and AI Innovation at the American Society of Transplantation Cutting Edge of Transplantation Meeting (Business Wire)
Feb-21-23 04:01PM	CareDx to Report Fourth Quarter and Full Year 2022 Financial Results (Business Wire) -13.72%
Feb-20-23 10:00AM	Analysts Estimate Viatris (VTRS) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-16-23 10:01AM	Earnings Preview: CareDx (CDNA) Q4 Earnings Expected to Decline (Zacks)
07:01AM	CareDx Showcases Latest Advancements in Cellular Transplant and Therapy Including Specialized Digital Health Solutions at the 2023 Tandem Meetings (Business Wire)
Feb-01-23 09:48AM	Cathie Wood pours millions into these 2 stocks this is what makes them attractive buys (TipRanks)
Jan-27-23 08:30AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
Jan-26-23 08:21AM	CareDx (NASDAQ:CDNA) delivers shareholders splendid 20% CAGR over 5 years, surging 9.8% in the last week alone (Simply Wall St.)
07:01AM	JACC Publication Guides Use of CareDxs HeartCare Transplant Rejection Surveillance in Clinical Practice (Business Wire)
Jan-11-23 07:01AM	CareDx Fosters Transplant Innovation as Distinguished Founders Circle Sponsor for the 23rd Annual American Society of Transplant Surgeons State of the Art Winter Symposium (Business Wire) +8.23%
Jan-09-23 07:00AM	CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2022 (Business Wire) +5.60%
Dec-21-22 06:00PM	New ISHLT Guidelines Support Use of CareDxs HeartCare Solutions, AlloMap and AlloSure, in Routine Monitoring of Heart Transplant Patients (Business Wire)
Dec-14-22 07:00AM	Voyager Therapeutics Appoints Grace E. Colón, Ph.D., to its Board of Directors (GlobeNewswire)
Dec-06-22 08:01AM	CareDx Announces $50 Million Stock Repurchase Program (Business Wire) +5.27%
Dec-05-22 03:49PM	13 Best Genomics Stocks To Buy Now (Insider Monkey) -5.22%
Dec-01-22 08:15AM	Independent Prospective Study Defines Reference Range for CareDxs AlloSure for Long-Term Lung Transplant Surveillance (Business Wire)
Nov-17-22 09:55AM	Here's Why CareDx (CDNA) Could be Great Choice for a Bottom Fisher (Zacks) +6.74%
Nov-11-22 09:35AM	CareDx (CDNA) Loses 22.5% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) +17.10%

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Maag Peter	Director	Apr 29 '24	Option Exercise	5.27	13,281	69,991	327,264	May 01 04:38 PM
Seeto Reginald	See Remarks	Oct 02 '23	Sale	6.91	2,818	19,483	479,164	Oct 02 07:53 PM
Seeto Reginald	See Remarks	Sep 05 '23	Sale	9.49	2,819	26,762	481,982	Sep 05 04:03 PM
Seeto Reginald	See Remarks	Aug 14 '23	Sale	8.89	576	5,123	484,801	Aug 14 07:52 PM
Bickerstaff George	Director	Aug 11 '23	Option Exercise	5.09	19,453	99,065	99,721	Aug 11 07:47 PM
Seeto Reginald	See Remarks	Aug 02 '23	Sale	11.35	2,819	31,988	486,051	Aug 02 06:53 PM
Seeto Reginald	See Remarks	Jul 13 '23	Sale	10.33	5,260	54,357	488,870	Jul 13 08:56 PM
Maag Peter	Director	Jul 13 '23	Sale	10.34	5,000	51,680	309,657	Jul 13 08:56 PM
Seeto Reginald	See Remarks	Jul 03 '23	Sale	8.48	2,818	23,901	498,055	Jul 03 05:19 PM
Seeto Reginald	See Remarks	Jun 28 '23	Sale	8.76	14,268	125,016	500,873	Jun 28 08:44 PM
Maag Peter	Director	Jun 28 '23	Sale	8.72	2,432	21,216	313,136	Jun 28 08:43 PM
Seeto Reginald	See Remarks	Jun 02 '23	Sale	8.13	2,819	22,911	532,177	Jun 02 08:08 PM

Open in Screener

INVA

Innoviva Inc

May 03 • 04:00PM ET

15.20

Dollar change -0.17
Percentage change -1.11	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Revenue • Options Chain • Save to Portfolio • Create Alert

Held by: IJR CALF VTI VB IWM VBR VXF PJP DFAT IWN

Index	RUT	P/E	6.96	EPS (ttm)	2.18	Insider Own	1.28%	Shs Outstand	62.52M	Perf Week	-0.39%
Market Cap	950.30M	Forward P/E	15.51	EPS next Y	0.98	Insider Trans	-1.36%	Shs Float	61.72M	Perf Month	3.68%
Income	179.72M	PEG	0.36	EPS next Q	0.17	Inst Own	117.70%	Short Float	18.67%	Perf Quarter	-4.40%
Sales	324.26M	P/S	2.93	EPS this Y	-63.18%	Inst Trans	-2.49%	Short Ratio	16.19	Perf Half Y	22.38%
Book/sh	10.66	P/B	1.43	EPS next Y	20.99%	ROA	14.52%	Short Interest	11.52M	Perf Year	31.83%
Cash/sh	3.10	P/C	4.91	EPS next 5Y	19.34%	ROE	28.97%	52W Range	11.40 - 16.86	Perf YTD	-5.24%
Dividend Est.	-	P/FCF	6.76	EPS past 5Y	-	ROI	16.01%	52W High	-9.87%	Beta	0.58
Dividend TTM	-	Quick Ratio	7.96	Sales past 5Y	-14.63%	Gross Margin	75.84%	52W Low	33.33%	ATR (14)	0.35
Dividend Ex-Date	Sep 08, 2015	Current Ratio	9.03	EPS Y/Y TTM	-9.93%	Oper. Margin	35.12%	RSI (14)	54.04	Volatility	2.89% 2.08%
Employees	-	Debt/Eq	0.67	Sales Y/Y TTM	-6.05%	Profit Margin	55.42%	Recom	3.00	Target Price	15.00
Option/Short	Yes / Yes	LT Debt/Eq	0.66	EPS Q/Q	177.63%	Payout	-	Rel Volume	0.60	Prev Close	15.37
Sales Surprise	13.67%	EPS Surprise	230.43%	Sales Q/Q	28.90%	Earnings	Feb 29 AMC	Avg Volume	711.76K	Price	15.20
SMA20	2.08%	SMA50	1.49%	SMA200	5.67%	Trades		Volume	428,631	Change	-1.11%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-20-22	Initiated	Goldman	Neutral	$16
Nov-20-17	Initiated	Deutsche Bank	Hold	$13

Apr-24-24 07:00AM	Innoviva Specialty Therapeutics Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024 (Business Wire)
Mar-04-24 04:01PM	Armata Pharmaceuticals Announces $35 Million Secured Credit Agreement with Innoviva (PR Newswire)
Feb-29-24 04:56PM	Innoviva: Q4 Earnings Snapshot (Associated Press Finance)
04:37PM	Innoviva Inc (INVA) Reports Growth Amidst Challenges in Q4 and Full Year 2023 Financial Results (GuruFocus.com)
04:05PM	Innoviva Reports Fourth Quarter and Full Year 2023 Financial Results; Highlights Recent Company Progress (Business Wire)
02:44AM	Loading…
Feb-14-24 02:44AM	Jim Simons Bolsters Position in Innoviva Inc with Recent Acquisition (GuruFocus.com)
Jan-10-24 06:16PM	If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names (InvestorPlace)
Nov-18-23 07:03AM	Insider Sell Alert: Marianne Zhen Offloads Shares of Innoviva Inc (GuruFocus.com)
Nov-03-23 06:00AM	Innoviva Inc (INVA) Reports Q3 2023 Financial Results: Net Income Drops to $82.0 Million (GuruFocus.com)
Nov-01-23 05:32PM	Innoviva: Q3 Earnings Snapshot (Associated Press Finance)
04:15PM	Innoviva Reports Third Quarter 2023 Financial Results and Highlights Recent Company Progress (Business Wire)
04:05PM	Positive Results Announced in Largest Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic to Treat Uncomplicated Gonorrhea (Business Wire)
Sep-19-23 08:30AM	Innoviva to Participate in the Cantor Global Healthcare Conference (Business Wire)
Sep-18-23 08:00AM	XACDURO®, The First and Only Antibiotic Developed to Target Acinetobacter, Now Available to Treat Hospital-Acquired Bacterial Pneumonia (HABP) and Ventilator-Associated Bacterial Pneumonia (VABP) in Adults (Business Wire)
Aug-25-23 04:52PM	Innoviva Appoints Stephen Basso as Chief Financial Officer (Business Wire)
05:18PM	Loading…
Aug-02-23 05:18PM	Innoviva: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Innoviva Reports Second Quarter 2023 Financial Results and Highlights Recent Company Progress (Business Wire)
Jul-23-23 09:22AM	Investors in Innoviva (NASDAQ:INVA) have unfortunately lost 11% over the last year (Simply Wall St.)
Jul-11-23 08:53PM	Why These 7 Stocks Are the Best Ways to Play Biotech Right Now (InvestorPlace)
08:00AM	Armata Pharmaceuticals Announces New Financing and Leadership Transition to Accelerate Novel Bacteriophage Therapeutics (PR Newswire)
Jul-06-23 11:33AM	12 Best Extremely Profitable Stocks to Buy (Insider Monkey)
Jun-26-23 01:27AM	Insider trades & hedge fund hits: Elliott aims to oust NRG chief (Investing.com)
Jun-21-23 08:00PM	INVA: What does Argus have to say about INVA? (Argus Research)
Jun-07-23 08:30AM	Do Its Financials Have Any Role To Play In Driving Innoviva, Inc.'s (NASDAQ:INVA) Stock Up Recently? (Simply Wall St.)
Jun-06-23 04:05PM	Innoviva to Participate in the Goldman Sachs Annual Global Healthcare Conference (Business Wire)
May-24-23 01:49PM	AstraZeneca-Spin Off Entasis Secures FDA Approval For First Pathogen-Targeted Therapy Addressing Acinetobacter (Benzinga)
May-23-23 06:42PM	Innoviva Specialty Therapeutics Announces FDA Approval for XACDURO® (sulbactam for injection; durlobactam for injection), Co-packaged for Intravenous Use (Business Wire)
May-11-23 06:45PM	Results from Pivotal Phase 3 ATTACK Trial of Investigational Sulbactam-Durlobactam for Treatment of Serious Infections Caused by Acinetobacter Published in The Lancet Infectious Diseases (Business Wire)
07:42AM	Is There An Opportunity With Innoviva, Inc.'s (NASDAQ:INVA) 35% Undervaluation? (Simply Wall St.)
May-09-23 07:45PM	Innoviva: Q1 Earnings Snapshot (AP Finance)
04:32PM	Loading…
04:32PM	Innoviva Reports First Quarter 2023 Financial Results and Highlights Recent Company Progress (Business Wire)
Apr-28-23 05:30PM	Innoviva Announces Retirement of Board Chairman (Business Wire)
Apr-26-23 08:00PM	INVA: Lowering target price to $9.00 (Argus Research)
Apr-18-23 11:22AM	FDA's AdComm Panel Favors Innoviva's Drug For Multidrug-Resistant Bacterial Infections (Benzinga) -5.16%
Apr-17-23 04:31PM	Sulbactam-Durlobactam Unanimously Recommended for Approval by FDA Advisory Committee (Business Wire)
09:40AM	Is Innoviva (INVA) Stock Undervalued Right Now? (Zacks)
09:00AM	Innoviva Stock Trading Halted Today (Business Wire)
Apr-10-23 08:38AM	Merck (MRK) Keytruda Studies in Difficult-to-Treat Cancers Fail (Zacks)
Apr-05-23 10:05AM	Pfizer (PFE) Gets FDA Acceptance for Braftovi + Mektovi sNDAs (Zacks)
09:53AM	J&J (JNJ) Offers $8.9B Settlement for Talc Cancer Lawsuits (Zacks)
Apr-03-23 12:09PM	AstraZeneca (AZN) Ultomiris Gets CHMP Nod for New Rare Disease (Zacks)
Mar-13-23 06:24PM	Innoviva Announces FDA Advisory Committee Meeting to Review Sulbactam-Durlobactam (SUL-DUR), an Investigational Targeted Antibiotic (Business Wire)
Feb-28-23 04:10PM	Innoviva Reports Fourth Quarter 2022 Financial Results and Highlights Recent Company Progress (Business Wire)
Feb-14-23 04:33PM	11 Most Undervalued Biotech Stocks To Buy According To Hedge Funds (Insider Monkey)
Feb-13-23 05:09AM	Shareholders in Innoviva (NASDAQ:INVA) are in the red if they invested a year ago (Simply Wall St.)
Jan-23-23 11:07AM	12 Most Undervalued Pharma Stocks To Buy According To Hedge Funds (Insider Monkey)
Jan-10-23 04:05PM	Armata Pharmaceuticals Announces Closing of $30 Million Secured Convertible Credit Agreement with Innoviva Strategic Opportunities LLC (PR Newswire)
Jan-03-23 06:15PM	Innoviva (INVA) Gains As Market Dips: What You Should Know (Zacks)
Dec-28-22 06:15PM	Innoviva (INVA) Stock Moves -1.06%: What You Should Know (Zacks)
11:07AM	Do Its Financials Have Any Role To Play In Driving Innoviva, Inc.'s (NASDAQ:INVA) Stock Up Recently? (Simply Wall St.)
Dec-22-22 06:00PM	Innoviva (INVA) Gains As Market Dips: What You Should Know (Zacks)
Dec-16-22 06:00PM	Innoviva (INVA) Dips More Than Broader Markets: What You Should Know (Zacks)
Nov-30-22 04:30PM	Innoviva Announces FDA Acceptance and Priority Review of New Drug Application for Sulbactam-Durlobactam (SUL-DUR) (Business Wire)
Nov-28-22 09:40AM	Should Value Investors Buy Innoviva (INVA) Stock? (Zacks)
Nov-18-22 08:48AM	Zacks.com featured highlights PBF Energy, Innoviva, Global Partners, Heritage-Crystal Clean and Sterling Infrastructure (Zacks)
Nov-17-22 07:11AM	5 Value Stocks With Attractive EV-to-EBITDA Ratios to Snap Up (Zacks)
Nov-11-22 09:40AM	Are Investors Undervaluing Innoviva (INVA) Right Now? (Zacks)
05:29AM	Innoviva Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag (Simply Wall St.)
Nov-09-22 06:35PM	Innoviva (INVA) Q3 Earnings and Revenues Lag Estimates (Zacks)
04:05PM	Innoviva Reports Third Quarter 2022 Financial Results and Highlights Recent Company Progress (Business Wire)
Oct-31-22 09:40AM	Is Bayer (BAYRY) a Great Value Stock Right Now? (Zacks)
Oct-20-22 10:02AM	Earnings Preview: Merck (MRK) Q3 Earnings Expected to Decline (Zacks)
Oct-19-22 10:01AM	Innoviva (INVA) Earnings Expected to Grow: Should You Buy? (Zacks)
08:00AM	Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Presents Efficacy and Safety Data from Landmark Phase 3 ATTACK Trial at IDWEEK 2022 (GlobeNewswire)
Oct-14-22 12:20PM	Surging Earnings Estimates Signal Upside for Innoviva (INVA) Stock (Zacks)
Oct-12-22 08:30AM	Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022 (GlobeNewswire)
Sep-19-22 02:28PM	Theravance Outlines $250M Capital Return Program; To Repurchase GSK's Entire Holdings (Benzinga)
Sep-08-22 07:00AM	Innoviva to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference (Business Wire)
Sep-05-22 11:43AM	Investing in Innoviva (NASDAQ:INVA) three years ago would have delivered you a 16% gain (Simply Wall St.)
Aug-22-22 08:55AM	Innoviva Completes Acquisition of La Jolla Pharmaceutical (Business Wire)
Jul-27-22 05:55PM	Innoviva (INVA) Misses Q2 Earnings Estimates (Zacks)
04:05PM	Innoviva Reports Second Quarter 2022 Financial Results and Highlights Recent Company Progress (Business Wire)
Jul-21-22 11:08AM	Could The Market Be Wrong About Innoviva, Inc. (NASDAQ:INVA) Given Its Attractive Financial Prospects? (Simply Wall St.)
Jul-20-22 10:01AM	Earnings Preview: Innoviva (INVA) Q2 Earnings Expected to Decline (Zacks)
Jul-14-22 06:04PM	Why 2 drug royalty deals worth close to $2 billion could signal the future (American City Business Journals)
Jul-13-22 05:29PM	Theravance Biopharma, Innoviva Gain On Selling TRELEGY ELLIPTA Royalty Interests (Benzinga)
04:32PM	Innoviva Sells 15% Economic Stake in Theravance Respiratory Company to Royalty Pharma for approximately $282 million plus full ownership of existing equity investments and the potential for $50 million milestone payment (Business Wire)
04:25PM	Royalty Pharma Agrees to Acquire Royalty Interest in TRELEGY ELLIPTA From Theravance and Innoviva for $1.31 Billion and Potential Milestones of $300 Million (GlobeNewswire)
Jul-12-22 01:35PM	Biotech M&A returns as Vertex, Innoviva make buys (American City Business Journals)
Jul-11-22 05:07PM	How this Peninsula company is turning lung drug royalties into acquisitions (American City Business Journals)
09:17AM	Innoviva Completes Acquisition of Entasis Therapeutics (Business Wire)
08:14AM	Innoviva Bolsters Its Infectious Disease, Hospital Portfolio With La Jolla Deal (Benzinga)
07:32AM	Innoviva to Acquire La Jolla Pharmaceutical Company (Business Wire)
Jul-08-22 08:35AM	Innoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc. (Business Wire)
May-24-22 03:03PM	Entasis (ETTX) Stock Rises on Buyout Offer From Innoviva (Zacks) -5.44%
02:06PM	AstraZeneca spinout, based in Waltham, acquired at 60% premium (American City Business Journals)
May-23-22 10:04AM	Innoviva Acquires AstraZeneca-Spin Off At $2.20/Share (Benzinga)
08:30AM	Innoviva to Acquire Entasis Therapeutics (GlobeNewswire)
Apr-27-22 06:45PM	Innoviva (INVA) Surpasses Q1 Earnings and Revenue Estimates (Zacks)
05:11PM	Innoviva Reports First Quarter 2022 Financial Results (Business Wire)
Apr-25-22 09:40AM	Is Bellus Health (BLU) Outperforming Other Medical Stocks This Year? (Zacks)
Apr-20-22 03:01PM	Earnings Preview: Innoviva (INVA) Q1 Earnings Expected to Decline (Zacks)
Apr-19-22 07:45AM	Johnson & Johnson (JNJ) Tops Q1 Earnings Estimates (Zacks)
Apr-11-22 12:52PM	4 Reasons to Add Novo Nordisk (NVO) Stock to Your Portfolio (Zacks)
Apr-08-22 12:26PM	Pfizer (PFE) to Boost RSV Portfolio With ReViral Acquisition (Zacks)
Apr-07-22 08:06AM	Zacks.com featured highlights include Meridian Bioscience, Innoviva, OP Bancorp and United Fire Group (Zacks)
Apr-06-22 11:58AM	Novartis (NVS) Gets FDA Nod for Vijoice in Rare Disorder (Zacks)
08:45AM	Bet on These 4 Low-Beta Stocks to Combat Market Volatility (Zacks)
Apr-01-22 09:40AM	Is Innoviva (INVA) Outperforming Other Medical Stocks This Year? (Zacks)
Mar-31-22 04:05PM	Armata Pharmaceuticals Announces Closing of Second and Final Tranche of $45 Million Private Placement with Innoviva (PR Newswire)

Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals. Its portfolio includes Relvar Breo Ellipta, which is a once-daily combination medicine consisting of a long-acting beta2 agonist, vilanterol, and an inhaled corticosteroid, fluticasone furoate, and Anoro Ellipta, a once-daily medicine combining a long-acting muscarinic antagonist, umeclidinium bromide, LABA, VI. The company was founded by P. Roy Vagelos, Mathai Mammen, and George M. Whitesides in November 1996 and is headquartered in Burlingame, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Zhen Marianne	Chief Accounting Officer	Nov 15 '23	Sale	13.99	10,994	153,810	40,158	Nov 17 04:30 PM
DENNER ALEXANDER J	10% Owner	Jun 06 '23	Buy	13.05	8,000	104,384	7,215,000	Jun 07 08:10 PM
DENNER ALEXANDER J	10% Owner	Jun 05 '23	Buy	13.04	7,000	91,297	7,207,000	Jun 07 08:10 PM
DENNER ALEXANDER J	10% Owner	May 30 '23	Buy	13.01	120,000	1,560,648	7,200,000	May 30 07:01 PM
DENNER ALEXANDER J	10% Owner	May 26 '23	Buy	13.12	30,000	393,729	7,080,000	May 30 07:01 PM
DENNER ALEXANDER J	10% Owner	May 25 '23	Buy	13.09	50,000	654,330	7,050,000	May 30 07:01 PM
DENNER ALEXANDER J	10% Owner	May 18 '23	Buy	13.05	10,000	130,538	6,964,000	May 19 08:00 PM
DENNER ALEXANDER J	10% Owner	May 17 '23	Buy	13.07	50,000	653,690	6,954,000	May 19 08:00 PM
DENNER ALEXANDER J	10% Owner	May 11 '23	Buy	12.34	290,000	3,577,411	6,904,000	May 15 09:09 PM

affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings

CDNA

Caredx Inc

INVA

Innoviva Inc

Upgrade your FINVIZ experience